The Gabelli Funds LLC Has $10,875,000 Position in Davita Inc (DVA)

The Gabelli Funds LLC Has $10,875,000 Position in Davita Inc (DVA)

Several other hedge funds have also recently modified their holdings of DVA. Hikari Power Ltd boosted its stake in shares of Davita by 5.6% in the third quarter. Hikari Power Ltd now owns 288,900 shares of the company’s stock worth $19,088,000 after buying an additional 15,400 shares during the last quarter. Emerald Acquisition Ltd. raised its position in shares of Davita by 18.6% in the third quarter. Emerald Acquisition Ltd. now owns 175,369 shares of the company’s stock worth $11,587,000 after buying an additional 27,490 shares during the period. Becker Capital Management Inc. raised its position in shares of Davita by 22.7% in the fourth quarter. Becker Capital Management Inc. now owns 681,865 shares of the company’s stock worth $43,776,000 after buying an additional 126,205 shares during the period. National Pension Service raised its stake in shares of Davita by 6.2% in the first quarter. National Pension Service now owns 155,161 shares of the company’s stock valued at $10,629,000 after buying an additional 9,075 shares during the period. Finally, Smith Shellnut Wilson LLC ADV acquired a new stake in shares of Davita during the fourth quarter valued at about $248,000. Institutional investors and hedge funds own 85.31% of the company’s stock.

Gabelli Funds LLC held its stake in shares of Davita Inc (NYSE:DVA) during the first quarter, according to its most recent disclosure with the SEC. The fund owned 160,000 shares of the company’s stock at the end of the first quarter. Gabelli Funds LLC owned 0.08% of Davita worth $10,875,000 at the end of the most recent reporting period.

Davita Inc (NYSE DVA) opened at 66.43 on Monday. The company has a market capitalization of $12.93 billion, a PE ratio of 10.91 and a beta of 1.02. The stock’s 50 day moving average is $66.53 and its 200 day moving average is $65.88. Davita Inc has a 52 week low of $54.50 and a 52 week high of $78.77.

DVA has been the topic of several analyst reports. Royal Bank of Canada reissued a “hold” rating and issued a $62.00 price target on shares of Davita in a report on Friday, February 17th. TheStreet upgraded shares of Davita from a “c+” rating to a “b-” rating in a research note on Monday, April 3rd. Zacks Investment Research upgraded shares of Davita from a “hold” rating to a “buy” rating and set a $77.00 target price on the stock in a research note on Tuesday, April 18th. Goldman Sachs Group Inc reiterated a “sell” rating and set a $62.00 price target on shares of Davita in a research report on Thursday, May 25th. Finally, Jefferies Group LLC set a $70.00 target price on shares of Davita and gave the company a “buy” rating in a research report on Friday, May 26th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. Davita presently has an average rating of “Hold” and a consensus price target of $69.50. In related news, Director William L. Roper sold 12,994 shares of the firm’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $65.89, for a total transaction of $856,174.66. Following the completion of the transaction, the director now owns 45,277 shares of the company’s stock, valued at approximately $2,983,301.53. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Charles Berg sold 8,414 shares of the firm’s stock in a transaction that occurred on Tuesday, May 9th. The shares were sold at an average price of $65.80, for a total value of $553,641.20. Following the transaction, the director now directly owns 34,719 shares of the company’s stock, valued at approximately $2,284,510.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,702 shares of company stock valued at $1,495,492. 2.10% of the stock is owned by corporate insiders.

Davita Company Profile DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “DVA”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Davita Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Davita Inc and related companies with our FREE daily email newsletter.

Related posts

Leave a Comment